Authors:
Lee, SB
Kim, SH
Bell, DW
Wahrer, DCR
Schiripo, TA
Jorczak, MM
Sgroi, DC
Garber, JE
Li, FP
Nichols, KE
Varley, JM
Godwin, AK
Shannon, KM
Harlow, E
Haber, DA
Citation: Sb. Lee et al., Destabilization of CHK2 by a missense mutation associated with Li-Fraumenisyndrome, CANCER RES, 61(22), 2001, pp. 8062-8067
Authors:
Rebbeck, TR
Wang, YT
Kantoff, PW
Krithivas, K
Neuhausen, SL
Godwin, AK
Daly, MB
Narod, SA
Brunet, JS
Vesprini, D
Garber, JE
Lynch, HT
Weber, BL
Brown, M
Citation: Tr. Rebbeck et al., Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history, CANCER RES, 61(14), 2001, pp. 5420-5424
Authors:
Rohlfs, EM
Puget, N
Graham, ML
Weber, BL
Garber, JE
Skrzynia, C
Halperin, JL
Lenoir, GM
Silverman, LM
Mazoyer, S
Citation: Em. Rohlfs et al., An Alu-mediated 7.1 kb deletion of BRCAI exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10, GENE CHROM, 28(3), 2000, pp. 300-307
Authors:
Lu, KH
Garber, JE
Cramer, DW
Welch, WR
Niloff, J
Schrag, D
Berkowitz, RS
Muto, MG
Citation: Kh. Lu et al., Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy, J CL ONCOL, 18(14), 2000, pp. 2728-2732
Authors:
Dorval, M
Patenaude, AF
Schneider, KA
Kieffer, SA
DiGianni, L
Kalkbrenner, KJ
Bromberg, JI
Basili, LA
Calzone, K
Stopfer, J
Weber, BL
Garber, JE
Citation: M. Dorval et al., Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: Findings from p53 and BRCA1 testing programs, J CL ONCOL, 18(10), 2000, pp. 2135-2142
Authors:
Syngal, S
Schrag, D
Falchuk, M
Tung, N
Farraye, FA
Chung, D
Wright, M
Whetsell, A
Miller, G
Garber, JE
Citation: S. Syngal et al., Phenotypic characteristics associated with the APC gene I1307K mutation inAshkenazi Jewish patients with colorectal polyps, J AM MED A, 284(7), 2000, pp. 857-860
Citation: D. Schrag et al., Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations, J AM MED A, 283(5), 2000, pp. 617-624
Citation: D. Schrag et al., Benefit of prophylactic mastectomy for women with BRCA1 or BRCA2 mutations- Reply, J AM MED A, 283(23), 2000, pp. 3071-3072
Authors:
Syngal, S
Fox, EA
Eng, C
Kolodner, RD
Garber, JE
Citation: S. Syngal et al., Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1, J MED GENET, 37(9), 2000, pp. 641-645
Authors:
Seth, P
Lunetta, KL
Bell, DW
Gray, H
Nasser, SM
Rhei, E
Kaelin, CM
Iglehart, DJ
Marks, JR
Garber, JE
Haber, DA
Polyak, K
Citation: P. Seth et al., Phenol sulfotransferases: Hormonal regulation, polymorphism, and age of onset of breast cancer, CANCER RES, 60(24), 2000, pp. 6859-6863
Authors:
Rebbeck, TR
Levin, AM
Eisen, A
Snyder, C
Watson, P
Cannon-Albright, L
Isaacs, C
Olopade, O
Garber, JE
Godwin, AK
Daly, MB
Narod, SA
Neuhausen, SL
Lynch, HT
Weber, BL
Citation: Tr. Rebbeck et al., Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers, J NAT CANC, 91(17), 1999, pp. 1475-1479
Authors:
Carlson, R
Barakat, R
Bevers, T
Daly, MB
Edge, S
Garber, JE
Gradishar, W
Mahoney, M
Sellin, RV
Shapiro, C
Singletary, E
Theriault, R
Ward, J
Whittemore, A
Williams, C
Winer, E
Citation: R. Carlson et al., NCCN breast cancer risk-reduction guidelines, ONCOLOGY-NY, 13(11A), 1999, pp. 241-254
Authors:
Syngal, S
Fox, EA
Li, C
Dovidio, M
Eng, C
Kolodner, RD
Garber, JE
Citation: S. Syngal et al., Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer - Implications for clinical predisposition testing, J AM MED A, 282(3), 1999, pp. 247-253
Authors:
Bell, DW
Varley, JM
Szydlo, TE
Kang, DH
Wahrer, DCR
Shannon, KE
Lubratovich, M
Verselis, SJ
Isselbacher, KJ
Fraumeni, JF
Birch, JM
Li, FP
Garber, JE
Haber, DA
Citation: Dw. Bell et al., Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome, SCIENCE, 286(5449), 1999, pp. 2528-2531
Authors:
Kolodner, RD
Tytell, JD
Schmeits, JL
Kane, MF
Das Gupta, R
Weger, J
Wahlberg, S
Fox, EA
Peel, D
Ziogas, A
Garber, JE
Syngal, S
Anton-Culver, H
Li, FP
Citation: Rd. Kolodner et al., Germ-line msh6 mutations in colorectal cancer families, CANCER RES, 59(20), 1999, pp. 5068-5074
Authors:
Alberts, DS
Colvin, GM
Conney, AH
Ernster, VL
Garber, JE
Greenwald, P
Gudas, LJ
Hong, WK
Kelloff, GJ
Kramer, RA
Lerman, CE
Mangelsdorf, DJ
Matter, A
Minna, JD
Nelson, WG
Pezzuto, JM
Prendergast, F
Rusch, VW
Sporn, MB
Wattenberg, LW
Weinstein, IB
Citation: Ds. Alberts et al., Prevention of cancer in the next millennium: Report of the ChemopreventionWorking Group to the American Association for Cancer Research, CANCER RES, 59(19), 1999, pp. 4743-4758
Authors:
Rebbeck, TR
Kantoff, PN
Krithivas, K
Neuhausen, S
Blackwood, MA
Godwin, AK
Daly, MB
Narod, SA
Garber, JE
Lynch, HT
Weber, BL
Brown, M
Citation: Tr. Rebbeck et al., Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat, AM J HU GEN, 64(5), 1999, pp. 1371-1377